Click Therapeutics to Present at the H.C. Wainwright 1st Annual Mental Health Conference

NEW YORK – June 23, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the H.C. Wainwright 1st Annual Mental Health Conference on Monday, June 27, 2022 at 11:00 a.m. ET.

The conference will be held in-person at the Lotte New York Palace Hotel in New York City and virtually. For additional information, please visit the conference website.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Migraine, Multiple Sclerosis, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome, Obesity, Oncology and more. For more information on Click, visit ClickTherapeutics.com.

Company Contact

Daniel Busby
VP, Investor Relations & Strategic Finance
dbusby@clicktherapeutics.com